Blueprint Medicines Corp Weighted Average Number of Shares Outstanding, Diluted from 2014 to Q1 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Blueprint Medicines Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2014 to Q1 2025.
  • Blueprint Medicines Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2025 was 66.5M shares, a 4.27% increase year-over-year.
  • Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 62.9M shares, a 3.8% increase from 2023.
  • Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 60.6M shares, a 1.54% increase from 2022.
  • Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 59.6M shares, a 1.92% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

Blueprint Medicines Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 66.5M +2.72M +4.27% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 62.9M +2.3M +3.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 63.4M +2.69M +4.44% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 62.9M +2.34M +3.86% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 63.8M +3.68M +6.11% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 60.6M +916K +1.54% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 60.7M +930K +1.56% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 60.5M +899K +1.51% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 60.1M +814K +1.37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 59.6M +1.12M +1.92% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 59.8M +1.11M +1.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 59.6M +1.21M +2.07% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 59.3M +1.29M +2.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 58.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 58.6M +1.86M +3.28% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 58.4M +4.19M +7.73% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 58M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 56.8M +7.87M +16.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 54.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q3 2019 48.9M +5.01M +11.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q1 2019 44.1M +397K +0.91% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 43.9M +6.07M +16.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-17
Q3 2018 43.9M +4.79M +12.2% Jul 1, 2018 Sep 30, 2018 10-Q 2018-10-30
Q2 2018 43.9M +5.08M +13.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-01
Q1 2018 43.7M +10.5M +31.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 37.8M +10.3M +37.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 39.1M +11.9M +43.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 38.8M +11.6M +42.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 33.2M +6.1M +22.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 27.5M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 27.3M Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 27.2M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 27.1M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03

Blueprint Medicines Corp Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 62.9M +2.3M +3.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 60.6M +916K +1.54% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 59.6M +1.12M +1.92% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 58.5M +2.35M +4.18% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 56.2M +8.34M +17.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 47.8M +3.96M +9.03% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-17
2018 43.9M +6.07M +16.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
2017 37.8M +10.3M +37.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-26
2016 27.5M +9.26M +50.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 18.2M +16.8M +1184% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
2014 1.42M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.